This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

M-M-R II

Merck & Co., Inc.

Drug Names(s): measles, mumps and rubella virus vaccine live, MMR II

Description: M-M-R II is a live virus vaccine for vaccinationagainst measles (rubeola), mumps, and rubella (German measles). It consists of a sterile lyophilized preparation of 1) ATTENUVAX (Measles Virus Vaccine Live), a more attenuated line of measles virus, derived from Enders' attenuated Edmonston strain and propagated in chick embryo cell culture; 2) MUMPSVAX (Mumps Virus Vaccine Live), the Jeryl Lynn (B level) strainof mumps virus propagated in chick embryo cell culture; and 3) MERUVAX II (Rubella Virus VaccineLive), the Wistar RA 27/3 strain of live attenuated rubella virus propagated in WI-38 human diploid lung fibroblasts.


M-M-R II News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug